Achillion Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW HAVEN, Conn., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two upcoming investor conferences:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC